ENANTA PHARMACEUTICALS, INC Income Tax Credits and Adjustments
ENANTA PHARMACEUTICALS, INC (ENTA) reported Income Tax Credits and Adjustments of -$750.00 thousand for the 12-month period ending 2011-09-30, per its 10-K filed 2013-12-18.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxCreditsAndAdjustments · last filed 2013-12-18
- ENANTA PHARMACEUTICALS, INC income tax credits and adjustments for fiscal 2011 was -$750.00K.
| Period end | Income Tax Credits and Adjustments 12 month |
|---|---|
| 2011-09-30 | -$750.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |